SEARCH

SEARCH BY CITATION

References

  • Anderson C. M. and Swanson R. A. (2000) Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32, 114.
  • Barger S. W., Goodwin M. E., Porter M. M. and Beggs M. L. (2007) Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J. Neurochem. 101, 12051213.
  • Boillée S., Yamanaka K., Lobsiger C. S., Copeland N. G., Jenkins N. A., Kassiotis G., Kollias G. and Cleveland D. W. (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 13891392.
  • Darman J., Backovic S., Dike S., Maragakis N. J., Krishnan C., Rothstein J. D., Irani D. N. and Kerr D. A. (2004) Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity. J. Neurosci. 24, 75667575.
  • Davis L. E., DeBiasi R., Goade D. E., Haaland K. Y., Harrington J. A., Harnar J. B., Pergam S. A., King M. K., DeMasters B. K. and Tyler K. L. (2006) West Nile virus neuroinvasive disease. Ann. Neurol. 60, 286300.
  • Dunlop J., Beal M. H., She Y. and Howland D. S. (2003) Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis. J. Neurosci. 23, 16881696.
  • Espey M. G., Kustova Y., Sei Y. and Basile A. S. (1998) Extracellular glutamate levels are chronically elevated in the brains of LP-BM5-infected mice: a mechanism of retrovirus-induced encephalopathy. J. Neurochem. 71, 20792087.
  • González M. I., Susarla B. T. and Robinson M. B. (2005) Evidence that protein kinase C alpha interacts with and regulates the glial glutamate transporter GLT-1. J. Neurochem. 94, 11801188.
  • Howland D. S., Liu J., She Y. et al. (2002) Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. USA 99, 16041609.
  • Irani D. N. and Prow N. A. (2007) Neuroprotective interventions targeting detrimental host immune responses protect mice from fatal alphavirus encephalitis. J. Neuropathol. Exp. Neurol. 66, 533544.
  • Jackson A. C., Moench T. R., Griffin D. E. and Johnson R. T. (1987) The pathogenesis of spinal cord involvement in the encephalomyelitis of mice caused by neuroadapted Sindbis virus infection. Lab. Invest. 56, 418423.
  • Kalandadze A., Wu Y. and Robinson M. B. (2002) Protein kinase C activation decreases cell surface expression of the GLT-1 subtype of glutamate transporter. Requirement of a carboxyl-terminal domain and partial dependence on serine 486. J. Biol. Chem. 277, 4574145750.
  • Korn T., Magnus T. and Jung S. (2005) Autoantigen specific T cells inhibit glutamate uptake in astrocytes by decreasing expression of astrocytic glutamate transporter GLAST: a mechanism mediated by tumor necrosis factor-alpha. FASEB J. 19, 18781880.
  • Li S., Mallory M., Alford M., Tanaka S. and Masliah E. (1997) Glutamate transporter alterations in Alzheimer’s disease are possibly associated with abnormal APP expression. J. Neuropathol. Exp. Neurol. 56, 901911.
  • Li L. B., Toan S. V., Zelenaia O., Watson D. J., Wolfe J. H., Rothstein J. D. and Robinson M. B. (2006) Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtype. J. Neurochem. 97, 759771.
  • Liang X. H., Goldman J. E., Jiang H. H. and Levine B. (1999) Resistance of interleukin-1beta-deficient mice to fatal Sindbis virus encephalitis. J. Virol. 73, 25632567.
  • Liu B. and Hong J. S. (2003) Neuroprotective effect of naloxone in inflammation-mediated dopaminergic neurodegeneration. Dissociation from the involvement of opioid receptors. Methods Mol. Med. 79, 4354.
  • Mallolas J., Hurtado O., Castellanos M. et al. (2006) A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. J. Exp. Med. 203, 711717.
  • Masliah E., Alford M., DeTeresa R., Mallory M. and Hansen L. (1996) Deficient glutamate transport is associated with neurodegeneration in Alzheimer’s disease. Ann. Neurol. 40, 759766.
  • McCarty M. F. (2006) Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders. Med. Hypotheses 67, 251269.
  • Miralles V. J., Martinez-Lopez I., Zaragoza R., Borras E., Garcia C., Pallardo F. V. and Vina J. R. (2001) Na+ dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) in primary astrocyte cultures: effects of oxidative stress. Brain Res. 922, 2129.
  • Moisse K. and Strong M. J. (2006) Innate immunity in amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1762, 10831093.
  • Nargi-Aizenman J. L. and Griffin D. E. (2001) Sindbis virus-induced neuronal death is both necrotic and apoptotic and is ameliorated by N-methyl-D-aspartate receptor antagonists. J. Virol. 75, 71147121.
  • Nargi-Aizenman J. L., Havert M. B., Zhang M., Irani D. N., Rothstein J. D. and Griffin D. E. (2004) Glutamate receptor antagonists protect from virus-induced neural degeneration. Ann. Neurol. 55, 541549.
  • Noda M., Nakanishi H. and Akaike N. (1999) Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience 92, 14651474.
  • Ohgoh M., Hanada T., Smith T., Hashimoto T., Ueno M., Yamanishi Y., Watanabe M. and Nishizawa Y. (2002) Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 125, 170178.
  • Pitt D., Werner P. and Raine C. S. (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nat. Med. 6, 6770.
  • Pitt D., Nagelmeier I. E., Wilson H. C. and Raine C. S. (2003) Glutamate uptake by oligodendrocytes: implications for excitotoxicity in multiple sclerosis. Neurology 61, 11131120.
  • Prow N. A. and Irani D. N. (2007) The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitis. Exp. Neurol. 205, 461470.
  • Qin L., Block M. L., Liu Y., Bienstock R. J., Pei Z., Zhang W., Wu X., Wilson B., Burka T. and Hong J. S. (2005) Microglial NADPH oxidase is a novel target for femtomolar neuroprotection against oxidative stress. FASEB J. 19, 550557.
  • Rothstein J. D., Martin L. J. and Kuncl R. W. (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326, 14641468.
  • Rothstein J. D., Van Kammen M. A., Levey I., Martin L. J. and Kuncl R. W. (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38, 7384.
  • Rothstein J. D., Dykes-Hoberg M., Pardo C. A. et al. (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675686.
  • Rothstein J. D., Patel S., Regan M. R. et al. (2005) Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433, 7377.
  • Simard A. R. and Rivest S. (2007) Neuroprotective effects of resident microglia following acute brain injury. J. Comp. Neurol. 504, 716729.
  • Sitcheran R., Gupta P., Fisher P. B. and Baldwin A. S. (2005) Positive and negative regulation of EAAT2 by NF-kappa B: a role for N-myc in TNF alpha-controlled repression. EMBO J. 24, 510520.
  • Smith T., Groom A., Zhu B. and Turski L. (2000) Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat. Med. 6, 6266.
  • Solomon T., Kneen R., Dung N. M., Khanh V. C., Thuv T. T., Ha D. O., Dav N. P., Nisalak A., Vaughn D. W. and White N. J. (1998) Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet 351, 10941097.
  • Srinivasan R., Sailasuta N., Hurd R., Nelson S. and Pelletier D. (2005) Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 128, 10161025.
  • Szymocha R., Akaoka H., Dutuit M., Malcus C., Didier-Bazes M., Belin M. F. and Giraudon P. (2000) Human T-cell lymphotropic virus type 1-infected lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha. J. Virol. 74, 64336441.
  • Takeuchi H., Jin S., Wang J., Zhang G., Kawanokuchi J., Kuno R., Sonobe Y., Mizuno T. and Suzumura A. (2006) Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem. 281, 2136221368.
  • Tanaka K., Watase K., Manabe T. et al. (1997) Epilepsy and exacerbarion of brain injury in mice lacking the glial glutamate transporter GLT-1. Science 276, 16991702.
  • Thach D. C., Kimura T. and Griffin D. E. (2000) Differences between C57BL/6 and BALB/cBy mice in mortality and virus replication after intranasal infection with neuroadapted Sindbis virus. J. Virol. 74, 61566161.
  • Tian G., Lai L., Guo H., Lin Y., Butchbach M. E., Chang Y. and Lin C. L. (2007) Translational control of glial glutamate transporter EAAT2 expression. J. Biol. Chem. 282, 17271737.
  • Tilleux S. and Hermans E. (2007) Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J. Neurosci. Res. 85, 20592070.
  • Trotti D., Rossi D., Gjesdal O., Levy L. M., Racagni G., Danbolt N. C. and Volterra A. (1996) Peroxynitrite inhibits glutamate transporter subtypes. J. Biol. Chem. 271, 59765979.
  • Vercellino M., Merola A., Piacentino C., Votta B., Capello E., Mancardi G. L., Mutani R., Giordana M. T. and Cavalla P. (2007) Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J. Neuropathol. Exp. Neurol. 66, 732739.
  • Volterra A., Trotti D., Tromba C., Floridi S. and Racagni G. (1994) Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14, 29242932.
  • Wang Z., Pekarskava O., Bencheikh M., Chao W., Gelbard H. A., Ghorpade A., Rothstein J. D. and Volsky D. J. (2003) Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology 20, 6073.
  • Wang Z., Trillo-Pazos G., Kim S. Y. et al. (2004) Effects of human immunodeficiency virus type 1 on astrocyte gene expression: potential role in neuropathogenesis. J. Neurovirol. 10 (Suppl), 2532.
  • Warita H., Manabe Y., Murakami T., Shiote M., Shiro Y., Hayashi T., Nagano I., Shoji M. and Abe K. (2002) Tardive decrease of astrocytic glutamate transporter protein in transgenic mice with ALS-linked mutant SOD1. Neurol. Res. 24, 577581.
  • Werner P., Pitt D. and Raine C. S. (2001) Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann. Neurol. 50, 169180.
  • Wyss-Coray T. (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. Med. 12, 10051015.
  • Ye Z. C. and Sontheimer H. (1996) Cytokine modulation of glial glutamate uptake: a possible involvement of nitric oxide. Neuroreport 7, 21812185.
  • Yong V. W., Wells J., Giuliani F., Casha S., Power C. and Metz L. M. (2004) The promise of minocycline in neurology. Lancet Neurol. 3, 744751.
  • Zhu S., Stavrovskaya I. G., Drozda M. et al. (2002) Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417, 7478.